The Combination of Berberine and Methotrexate Enhances Anti-Cancer Effects in Hela Cancer Cell Line: A Morphological Study
Background: Co-administration of two or several either chemotherapeutic agents or conventional drugs as a combination treatment is the most effective method to increase therapeutic efficiency. Additive or synergistic influence are two mechanisms by which combination therapy causes a rise in optimal...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Tabriz University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dde0705bc4b14d4b882963ec9d3e323b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:dde0705bc4b14d4b882963ec9d3e323b |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:dde0705bc4b14d4b882963ec9d3e323b2021-11-29T05:53:09ZThe Combination of Berberine and Methotrexate Enhances Anti-Cancer Effects in Hela Cancer Cell Line: A Morphological Study2383-288610.34172/PS.2021.12https://doaj.org/article/dde0705bc4b14d4b882963ec9d3e323b2021-12-01T00:00:00Zhttps://ps.tbzmed.ac.ir/PDF/ps-27-536.pdfhttps://doaj.org/toc/2383-2886Background: Co-administration of two or several either chemotherapeutic agents or conventional drugs as a combination treatment is the most effective method to increase therapeutic efficiency. Additive or synergistic influence are two mechanisms by which combination therapy causes a rise in optimal cancer therapy compared to a single treatment. Methods: Colorimetric assay was carried out to estimate the cytotoxicity of the combined system, followed by apoptosis assay to calculate the number of apoptotic cells. Both 4′,6-diamidino-2-phenylindole (DAPI) staining and DNA ladder were complemented tests to illuminate morphological changes and DNA fracturing on HeLa cancer cells. Results: We revealed that the combination of berberine (BER) and methotrexate (MTX) could inhibit the growth of HeLa cancer cells noticeably. Nevertheless, single BER and MTX were not as effective as a combined system to reduce cell viability at the same dose. Regarding the apoptosis induction and change in morphology of cancer cells’ nucleus, co-treatment of BERand MTX was more effective. The result was complemented with flow cytometry, DAPI staining and DNA ladder, which showed that BER+MTX depicted more anti-cancer effects. Conclusion: The combination therapy of HeLa cancer cells with BER and MTX showed high inhibition effect compared to other treated groups.Hossein MajidzadehMostafa Araj-KhodaeiMaryam GhaffariAmir JafariDariush ShanehbandiMohammadali TorbatiJafar Ezzati Nazhad DolatabadiTabriz University of Medical Sciencesarticlehela cellsmethotrexateberberineherbal medicinenuclear morphologyPharmacy and materia medicaRS1-441ENPharmaceutical Sciences, Vol 27, Iss 4, Pp 536-542 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
hela cells methotrexate berberine herbal medicine nuclear morphology Pharmacy and materia medica RS1-441 |
spellingShingle |
hela cells methotrexate berberine herbal medicine nuclear morphology Pharmacy and materia medica RS1-441 Hossein Majidzadeh Mostafa Araj-Khodaei Maryam Ghaffari Amir Jafari Dariush Shanehbandi Mohammadali Torbati Jafar Ezzati Nazhad Dolatabadi The Combination of Berberine and Methotrexate Enhances Anti-Cancer Effects in Hela Cancer Cell Line: A Morphological Study |
description |
Background: Co-administration of two or several either chemotherapeutic agents or conventional drugs as a combination treatment is the most effective method to increase therapeutic efficiency. Additive or synergistic influence are two mechanisms by which combination therapy causes a rise in optimal cancer therapy compared to a single treatment. Methods: Colorimetric assay was carried out to estimate the cytotoxicity of the combined system, followed by apoptosis assay to calculate the number of apoptotic cells. Both 4′,6-diamidino-2-phenylindole (DAPI) staining and DNA ladder were complemented tests to illuminate morphological changes and DNA fracturing on HeLa cancer cells. Results: We revealed that the combination of berberine (BER) and methotrexate (MTX) could inhibit the growth of HeLa cancer cells noticeably. Nevertheless, single BER and MTX were not as effective as a combined system to reduce cell viability at the same dose. Regarding the apoptosis induction and change in morphology of cancer cells’ nucleus, co-treatment of BERand MTX was more effective. The result was complemented with flow cytometry, DAPI staining and DNA ladder, which showed that BER+MTX depicted more anti-cancer effects. Conclusion: The combination therapy of HeLa cancer cells with BER and MTX showed high inhibition effect compared to other treated groups. |
format |
article |
author |
Hossein Majidzadeh Mostafa Araj-Khodaei Maryam Ghaffari Amir Jafari Dariush Shanehbandi Mohammadali Torbati Jafar Ezzati Nazhad Dolatabadi |
author_facet |
Hossein Majidzadeh Mostafa Araj-Khodaei Maryam Ghaffari Amir Jafari Dariush Shanehbandi Mohammadali Torbati Jafar Ezzati Nazhad Dolatabadi |
author_sort |
Hossein Majidzadeh |
title |
The Combination of Berberine and Methotrexate Enhances Anti-Cancer Effects in Hela Cancer Cell Line: A Morphological Study |
title_short |
The Combination of Berberine and Methotrexate Enhances Anti-Cancer Effects in Hela Cancer Cell Line: A Morphological Study |
title_full |
The Combination of Berberine and Methotrexate Enhances Anti-Cancer Effects in Hela Cancer Cell Line: A Morphological Study |
title_fullStr |
The Combination of Berberine and Methotrexate Enhances Anti-Cancer Effects in Hela Cancer Cell Line: A Morphological Study |
title_full_unstemmed |
The Combination of Berberine and Methotrexate Enhances Anti-Cancer Effects in Hela Cancer Cell Line: A Morphological Study |
title_sort |
combination of berberine and methotrexate enhances anti-cancer effects in hela cancer cell line: a morphological study |
publisher |
Tabriz University of Medical Sciences |
publishDate |
2021 |
url |
https://doaj.org/article/dde0705bc4b14d4b882963ec9d3e323b |
work_keys_str_mv |
AT hosseinmajidzadeh thecombinationofberberineandmethotrexateenhancesanticancereffectsinhelacancercelllineamorphologicalstudy AT mostafaarajkhodaei thecombinationofberberineandmethotrexateenhancesanticancereffectsinhelacancercelllineamorphologicalstudy AT maryamghaffari thecombinationofberberineandmethotrexateenhancesanticancereffectsinhelacancercelllineamorphologicalstudy AT amirjafari thecombinationofberberineandmethotrexateenhancesanticancereffectsinhelacancercelllineamorphologicalstudy AT dariushshanehbandi thecombinationofberberineandmethotrexateenhancesanticancereffectsinhelacancercelllineamorphologicalstudy AT mohammadalitorbati thecombinationofberberineandmethotrexateenhancesanticancereffectsinhelacancercelllineamorphologicalstudy AT jafarezzatinazhaddolatabadi thecombinationofberberineandmethotrexateenhancesanticancereffectsinhelacancercelllineamorphologicalstudy AT hosseinmajidzadeh combinationofberberineandmethotrexateenhancesanticancereffectsinhelacancercelllineamorphologicalstudy AT mostafaarajkhodaei combinationofberberineandmethotrexateenhancesanticancereffectsinhelacancercelllineamorphologicalstudy AT maryamghaffari combinationofberberineandmethotrexateenhancesanticancereffectsinhelacancercelllineamorphologicalstudy AT amirjafari combinationofberberineandmethotrexateenhancesanticancereffectsinhelacancercelllineamorphologicalstudy AT dariushshanehbandi combinationofberberineandmethotrexateenhancesanticancereffectsinhelacancercelllineamorphologicalstudy AT mohammadalitorbati combinationofberberineandmethotrexateenhancesanticancereffectsinhelacancercelllineamorphologicalstudy AT jafarezzatinazhaddolatabadi combinationofberberineandmethotrexateenhancesanticancereffectsinhelacancercelllineamorphologicalstudy |
_version_ |
1718407616306085888 |